Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
OpenAI Addresses Security Vulnerability in macOS App Certification Process 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 
TSMC Posts Record Q1 2026 Profits Driven by Surging AI Chip Demand 
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Regenerative Medicine in US$ Million.
The report profiles 52 companies including many key and niche players such as
- AlloSource (US)
- Anika Therapeutics, Inc. (US)
- Bioventus LLC (US)
- DePuy Synthes Companies (US)
- DePuy Synthes Spine, Inc. (US)
- Exactech, Inc. (US)
- Integra LifeSciences Holdings Corp. (US)
- LifeNet Health, Inc. (US)
- Medtronic, plc (Ireland)
- NovaBone Products LLC (US)
- NuVasive, Inc. (US)
- Orthofix International N.V. (Netherlands)
- Osiris Therapeutics, Inc. (US)
- Smith & Nephew plc (UK)
- Stryker Corporation (US)
- Wright Medical Technology, Inc. (US)
- Zimmer Biomet Holdings, Inc. (US)
Key Topics Covered:
1. Outlook
2. Regenerative Medicine A Macro Perspective
3. Bone And Joint Regenerative Medicine An Overview
4. Competitive Landscape
5. Regenerative Medicine In Other Areas
6. Regulatory Environment
7. A Peek Into The Global Orthopedic Industry
8. Product Overview
9. Product Innovations/Introductions
10. Recent Industry Activity
11. Focus On Select Players
12. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 54)
- The United States (37)
- Canada (3)
- Japan (1)
- Europe (10)
- Germany (2)
- The United Kingdom (2)
- Rest of Europe (6)
- Asia-Pacific (Excluding Japan) (1)
- Middle East (1)
- Africa (1)
For more information about this report visit http://www.researchandmarkets.com/research/zzvd55/regenerative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals
